The Effects of Green Tea and Salvadora Persica L. in Patients With Gingivitis
Evaluation of Anti-plaque and Anti-inflammatory Effects of Green Tea and Salvadora Persica L. in Patients With Gingivitis
1 other identifier
interventional
45
1 country
1
Brief Summary
Gingivitis is an inflammatory condition of the gingival tissue, most commonly caused by bacterial infection.The plaque control is considered the most important preventive factor concerning caries, gingivitis, and periodontitis Mechanical means of plaque control, e.g. tooth brushing, flossing and use of other mechanical devices are the most commonly used methods. However, ideal plaque control solely by mechanical means requires a significant effort and is difficult to achieve.This has led to the introduction of chemical methods of plaque control using antimicrobial agentsMore specifically, chemotherapeutic agents with antimicrobial properties, such as 0.12% chlorhexidine (CHX).chx has side effects encourage the need to develop alternative mouthwashes with similar efficacy but without these issues.hence the mouthwash enriched with a combination of aqueous extracts of Salvadora persica L. and green tea used as a substitution to CHX with minimal side effects .The objective of this study was to investigate the efficacy of the combination of Gt aqueous extract and Sp aqueous extract in reducing plaque buildup and gingivitis for 4 weeks duration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jan 2024
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
January 8, 2024
CompletedFirst Posted
Study publicly available on registry
January 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedJanuary 30, 2024
January 1, 2024
4 months
January 8, 2024
January 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
change in plaque index
Mean amount plaque between different comparators. Mean amount plaque between different comparators as anti-plaque agent after rinsing with different comparators using means of modified quigely hein plaque index\[ Turesky ,1970
0-30 days
Secondary Outcomes (3)
Change in BOP score
0-30 Days
change in Gingival index
0-30 days
Mean relative change in cytokine interleukin-6 level in salivary Fluid
0-30 days
Study Arms (3)
co.mouthwash
ACTIVE COMPARATOR15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Kin mouthwash
PLACEBO COMPARATOR15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Distilled water
PLACEBO COMPARATOR15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Interventions
15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
15ml twice a day, rinse for 30sec refrain from eating or drinking for 30min
Eligibility Criteria
You may qualify if:
- Subjects aged more than 15 years-old who will volunteer to participate.
- Participants who were apparently systemically healthy.
- Not taking antibiotic and anti-inflammatory drugs in the last three months
- Patients having generalized gingivitis with intact periodontium in which they have more than 30% bleeding sites with no PPD \>3 mm with no clinical attachment loss according to criteria proposed by
You may not qualify if:
- Those with history of systemic chronic disease, immunocompromised patients.
- Those currently using any mouthwash.
- Those on antibiotic therapy, anti-inflammatory medications or NSAID during the study and at the last 3 months before the study.
- Those having a history of hypersensitivity to any product used in the present study.
- Those having periodontitis.
- Those who smoker or alcoholism.
- handicapped patient or patients with limited manual dexterities.
- pregnant , lactating women or taking contraceptive pills.
- Subjects wearing orthodontic appliances or removable dentures.
- patients unwilling to participate in study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aliaa
Baghdad, 10011, Iraq
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
January 8, 2024
First Posted
January 18, 2024
Study Start
January 1, 2024
Primary Completion
May 1, 2024
Study Completion
July 1, 2024
Last Updated
January 30, 2024
Record last verified: 2024-01